Author | Enriqueta Felip, MD, PhD | OncLive

Author | Enriqueta Felip, MD, PhD

Articles

Dr. Felip Discusses Ceritinib's Response in ALK+ NSCLC

November 12, 2014

Video

Enriqueta Felip, MD, PhD, medical oncologist, Vall d'Hebron University Hospital, Barcelona, Spain, discusses the efficacy and safety of ceritinib in patients with ALK-positive non-small cell lung cancer (NSCLC).

x